Sernova Biotherapeutics Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Equivalents	0.27	6.01	8.72	3.78	27.87
Short-Term Investments	-	-	11.08	46	-
Cash & Short-Term Investments	0.27	6.01	19.81	49.78	27.87
Cash Growth	-95.59%	-69.64%	-60.21%	78.57%	605.78%
Accounts Receivable	0.12	0.3	1.05	1.15	0.45
Other Current Assets	0.14	0.16	0.16	0.17	0
Total Current Assets	0.52	6.47	21.02	51.09	28.33
Net Property, Plant & Equipment	0.02	0.83	0.51	0.65	0.56
Other Intangible Assets	-	-	0.32	0.52	0.72
Other Long-Term Assets	0.22	0.22	0.26	0.22	0.21
Total Assets	0.76	7.53	22.11	52.48	29.82
Accounts Payable	21.07	19.91	9.46	4.6	1.36
Short-Term Debt	3.73	-	-	-	-
Current Portion of Leases	-	0.1	0.14	0.14	0.12
Total Current Liabilities	24.8	20.02	9.59	4.74	1.48
Long-Term Debt	1.04	-	-	-	-
Long-Term Leases	-	0.47	-	0.14	0.28
Total Long-Term Liabilities	1.04	0.47	-	0.14	0.28
Total Liabilities	25.84	20.48	9.59	4.88	1.75
Common Stock	118.7	116.68	110.99	110.99	74.01
Additional Paid-in Capital	22.33	20.72	19.69	15.79	8.81
Retained Earnings	-166.1	-150.36	-118.17	-79.17	-54.75
Shareholders' Equity	-25.08	-12.96	12.51	47.61	28.07
Total Liabilities & Equity	0.76	7.53	22.11	52.48	29.82
Total Debt	4.77	0.57	0.14	0.28	0.39
Net Cash (Debt)	-4.51	5.44	19.67	49.5	27.48
Net Cash Growth	-	-72.33%	-60.26%	80.13%	746.40%
Net Cash Per Share	-	0.02	0.07	0.18	0.11
Book Value	-25.08	-12.96	12.51	47.61	28.07
Book Value Per Share	-	-0.04	0.04	0.17	0.11
Tangible Book Value	-25.08	-12.96	12.2	47.09	27.35
Tangible Book Value Per Share	-	-0.04	0.04	0.17	0.11

Updated Oct 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.